Description

Buy BPC-157 + TB-500 Blend Vial Canada This product is intended for laboratory research purposes only. It should only be used by trained research professionals. The BPC-157 + TB-500 10mg blend from Tested Peptides is a precise tool designed to simplify laboratory workflows. This product consists of a standalone vial. Explore our full range of Vials for sale at Tested Peptides, your trusted source for research peptides.

Product Information:

• Chemical Formula: C62H98N16O22 (BPC-157) / C212H350N56O78S (TB-500)

• Peptide Category: Tissue Regeneration Blends, Healing & Recovery Peptides, Cellular Mobility.

• Mechanism of Action: This blend investigates the synergistic pathways of two profound regenerative peptides. BPC-157 modulates the nitric oxide (NO) system and upregulates VEGF for angiogenesis (new blood vessel formation). Concurrently, TB-500 sequesters actin monomers, facilitating rapid cellular migration to sites of damage.

• Primary Research Applications: Widely utilized in animal models to study the accelerated healing of complex, multi-tissue injuries. Researchers observe the combined efficacy on tendon-to-bone healing, skeletal muscle regeneration, and profound reductions in localized inflammation.

Potential Side Effects (Research Context): Transient behavioral changes or mild localized irritation at the administration site in animal models. How Should Vials Be Stored? Refrigerate at 2-8°C (35-46°F). Prevent freezing or exposing them to direct sunlight.

DISCLAIMER: This product is for research use only and not for human consumption. We are not responsible for any misusing or using on humans or animals, and it is for educational purposes only. ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY. These products are intended solely as a research chemical. This classification allows for their use only for research development and laboratory studies. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.